LifeMD Shares Fall as 4Q, FY Revenue Outlook Miss Following Divestment

Dow Jones11-18

By Katherine Hamilton

LifeMD shares slid after the company lowered its full-year sales guidance following its divestiture from WorkSimpli.

The stock slipped 22% to $3.67 in after-hours trading Monday. Through the close shares were down 4.5% this year.

In the current fourth quarter, the telehealth company forecasts revenue of $45 million to $46 million, missing the $65.2 million analysts polled by FactSet were expecting.

The company's full-year outlook for sales of $192 million to $193 million was below the $252.6 million analysts anticipated. LifeMD had previously been forecasting full-year revenue of $250 million to $255 million.

Earlier this month, LifeMD said it was divesting its interest in the document-management platform WorkSimpli. The new guidance reflects the divestiture, including a $1.1 million adjustment for the year, the company said.

LifeMD also said the weight-management market has remained challenged due to fierce competition from low-price compounded GLP-1 providers.

For the third quarter, the company said revenue increased 13% to $60.2 million, which was below the $62.1 million forecast by Wall Street.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

November 17, 2025 18:45 ET (23:45 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2584608489?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 07:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584608489","market":"fut","top_or_hot":-1,"title":"LifeMD Shares Fall as 4Q, FY Revenue Outlook Miss Following Divestment","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  LifeMD shares slid after the company lowered its full-year sales guidance following its divestiture from WorkSimpli. \n</p>\n<p>\n  The stock slipped 22% to $3.67 in after-hours trading Monday. Through the close shares were down 4.5% this year. \n</p>\n<p>\n  In the current fourth quarter, the telehealth company forecasts revenue of $45 million to $46 million, missing the $65.2 million analysts polled by FactSet were expecting. \n</p>\n<p>\n  The company's full-year outlook for sales of $192 million to $193 million was below the $252.6 million analysts anticipated. LifeMD had previously been forecasting full-year revenue of $250 million to $255 million. \n</p>\n<p>\n  Earlier this month, LifeMD said it was divesting its interest in the document-management platform WorkSimpli. The new guidance reflects the divestiture, including a $1.1 million adjustment for the year, the company said. \n</p>\n<p>\n  LifeMD also said the weight-management market has remained challenged due to fierce competition from low-price compounded GLP-1 providers. \n</p>\n<p>\n  For the third quarter, the company said revenue increased 13% to $60.2 million, which was below the $62.1 million forecast by Wall Street. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 17, 2025 18:45 ET (23:45 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LifeMD Shares Fall as 4Q, FY Revenue Outlook Miss Following Divestment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLifeMD Shares Fall as 4Q, FY Revenue Outlook Miss Following Divestment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-18 07:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  LifeMD shares slid after the company lowered its full-year sales guidance following its divestiture from WorkSimpli. \n</p>\n<p>\n  The stock slipped 22% to $3.67 in after-hours trading Monday. Through the close shares were down 4.5% this year. \n</p>\n<p>\n  In the current fourth quarter, the telehealth company forecasts revenue of $45 million to $46 million, missing the $65.2 million analysts polled by FactSet were expecting. \n</p>\n<p>\n  The company's full-year outlook for sales of $192 million to $193 million was below the $252.6 million analysts anticipated. LifeMD had previously been forecasting full-year revenue of $250 million to $255 million. \n</p>\n<p>\n  Earlier this month, LifeMD said it was divesting its interest in the document-management platform WorkSimpli. The new guidance reflects the divestiture, including a $1.1 million adjustment for the year, the company said. \n</p>\n<p>\n  LifeMD also said the weight-management market has remained challenged due to fierce competition from low-price compounded GLP-1 providers. \n</p>\n<p>\n  For the third quarter, the company said revenue increased 13% to $60.2 million, which was below the $62.1 million forecast by Wall Street. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 17, 2025 18:45 ET (23:45 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4183","symbol_name":"个人用品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2584608489","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584608489","pubTimestamp":1763423100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"LifeMD shares slid after the company lowered its full-year sales guidance following its divestiture from WorkSimpli.The stock slipped 22% to $3.67 in after-hours trading Monday. Through the close shares were down 4.5% this year.In the current fourth quarter, the telehealth company forecasts revenue of $45 million to $46 million, missing the $65.2 million analysts polled by FactSet were expecting.The company's full-year outlook for sales of $192 million to $193 million was below the $252.6 million analysts anticipated. LifeMD had previously been forecasting full-year revenue of $250 million to $255 million.Earlier this month, LifeMD said it was divesting its interest in the document-management platform WorkSimpli. The new guidance reflects the divestiture, including a $1.1 million adjustment for the year, the company said.LifeMD also said the weight-management market has remained challenged due to fierce competition from low-price compounded GLP-1 providers.For the third quarter, the co","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4183":"个人用品","BK4167":"医疗保健技术","LFMD":"LifeMD Inc."},"translate_title":"撤资后，LifeMD股价下跌，第四季度和财年收入前景未达预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFMD":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  LifeMD shares slid after the company lowered its full-year sales guidance following its divestiture from WorkSimpli. \n\n\n  The stock slipped 22% to $3.67 in after-hours trading Monday. Through the close shares were down 4.5% this year. \n\n\n  In the current fourth quarter, the telehealth company forecasts revenue of $45 million to $46 million, missing the $65.2 million analysts polled by FactSet were expecting. \n\n\n  The company's full-year outlook for sales of $192 million to $193 million was below the $252.6 million analysts anticipated. LifeMD had previously been forecasting full-year revenue of $250 million to $255 million. \n\n\n  Earlier this month, LifeMD said it was divesting its interest in the document-management platform WorkSimpli. The new guidance reflects the divestiture, including a $1.1 million adjustment for the year, the company said. \n\n\n  LifeMD also said the weight-management market has remained challenged due to fierce competition from low-price compounded GLP-1 providers. \n\n\n  For the third quarter, the company said revenue increased 13% to $60.2 million, which was below the $62.1 million forecast by Wall Street. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 17, 2025 18:45 ET (23:45 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584608489","isCrawlerRequest":true}